NCT03201965 · Interventional trial
A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis
Overall registry status Completed
Phase 3
Conditions Amyloidosis
Delaware Valley sites
- University of Pennsylvania Medical Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory